Clinical Trial Update: Ziprasidone vs Standard Therapy for Agitated Patients in the ED [Phase 4]

View source ↗

Summary

Phase 4 trial investigating ziprasidone versus standard therapy for agitation in emergency department patients; the study was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Agitation
• Delirium
• Psychosis

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: George Washington University | Conditions: Psychosis, Agitation | Phase 4 | Status: WITHDRAWN